United States Metabolism Drugs Market Report 2016

Publisher Name :
Date: 13-Oct-2016
No. of pages: 115
Inquire Before Buying

Notes:

Sales, means the sales volume of Metabolism Drugs

Revenue, means the sales value of Metabolism Drugs

This report studies sales (consumption) of Metabolism Drugs in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

- Merck

- Novartis

- Takeda Pharmaceutical

- Astra Zeneca

- Beohrigher Ingelheim

- KOWA

- Kythera

- Fuji yakuhin

- LG Life Science

- Metsubishi Tanabe Pharma

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

- Glycogen Metabolism Disease Drug

- Lipid Metabolism Disease Drug

- Amino Acid Metabolism Drug

- Other

Split by applications, this report focuses on sales, market share and growth rate of Metabolism Drugs in each application, can be divided into

- Hospital

- Retail Pharmacy

- Others

United States Metabolism Drugs Market Report 2016

Table of Contents
United States Metabolism Drugs Market Report 2016
1 Metabolism Drugs Overview
1.1 Product Overview and Scope of Metabolism Drugs
1.2 Classification of Metabolism Drugs
1.2.1 Glycogen Metabolism Disease Drug
1.2.2 Lipid Metabolism Disease Drug
1.2.3 Amino Acid Metabolism Drug
1.2.4 Other
1.3 Application of Metabolism Drugs
1.3.1 Hospital
1.3.2 Retail Pharmacy
1.3.3 Others
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Metabolism Drugs (2011-2021)
1.4.1 United States Metabolism Drugs Sales and Growth Rate (2011-2021)
1.4.2 United States Metabolism Drugs Revenue and Growth Rate (2011-2021)
2 United States Metabolism Drugs Competition by Manufacturers
2.1 United States Metabolism Drugs Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Metabolism Drugs Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Metabolism Drugs Average Price by Manufactures (2015 and 2016)
2.4 Metabolism Drugs Market Competitive Situation and Trends
2.4.1 Metabolism Drugs Market Concentration Rate
2.4.2 Metabolism Drugs Market Share of Top 3 and Top 5 Manufacturers
2.4.3 Mergers & Acquisitions, Expansion
3 United States Metabolism Drugs Sales (Volume) and Revenue (Value) by Type (2011-2016)
3.1 United States Metabolism Drugs Sales and Market Share by Type (2011-2016)
3.2 United States Metabolism Drugs Revenue and Market Share by Type (2011-2016)
3.3 United States Metabolism Drugs Price by Type (2011-2016)
3.4 United States Metabolism Drugs Sales Growth Rate by Type (2011-2016)
4 United States Metabolism Drugs Sales (Volume) by Application (2011-2016)
4.1 United States Metabolism Drugs Sales and Market Share by Application (2011-2016)
4.2 United States Metabolism Drugs Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities
5 United States Metabolism Drugs Manufacturers Profiles/Analysis
5.1 Merck
5.1.1 Company Basic Information, Manufacturing Base and Competitors
5.1.2 Metabolism Drugs Product Type, Application and Specification
5.1.2.1 Type I
5.1.2.2 Type II
5.1.3 Merck Metabolism Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
5.1.4 Main Business/Business Overview
5.2 Novartis
5.2.2 Metabolism Drugs Product Type, Application and Specification
5.2.2.1 Type I
5.2.2.2 Type II
5.2.3 Novartis Metabolism Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
5.2.4 Main Business/Business Overview
5.3 Takeda Pharmaceutical
5.3.2 Metabolism Drugs Product Type, Application and Specification
5.3.2.1 Type I
5.3.2.2 Type II
5.3.3 Takeda Pharmaceutical Metabolism Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
5.3.4 Main Business/Business Overview
5.4 Astra Zeneca
5.4.2 Metabolism Drugs Product Type, Application and Specification
5.4.2.1 Type I
5.4.2.2 Type II
5.4.3 Astra Zeneca Metabolism Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
5.4.4 Main Business/Business Overview
5.5 Beohrigher Ingelheim
5.5.2 Metabolism Drugs Product Type, Application and Specification
5.5.2.1 Type I
5.5.2.2 Type II
5.5.3 Beohrigher Ingelheim Metabolism Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
5.5.4 Main Business/Business Overview
5.6 KOWA
5.6.2 Metabolism Drugs Product Type, Application and Specification
5.6.2.1 Type I
5.6.2.2 Type II
5.6.3 KOWA Metabolism Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
5.6.4 Main Business/Business Overview
5.7 Kythera
5.7.2 Metabolism Drugs Product Type, Application and Specification
5.7.2.1 Type I
5.7.2.2 Type II
5.7.3 Kythera Metabolism Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
5.7.4 Main Business/Business Overview
5.8 Fuji yakuhin
5.8.2 Metabolism Drugs Product Type, Application and Specification
5.8.2.1 Type I
5.8.2.2 Type II
5.8.3 Fuji yakuhin Metabolism Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
5.8.4 Main Business/Business Overview
5.9 LG Life Science
5.9.2 Metabolism Drugs Product Type, Application and Specification
5.9.2.1 Type I
5.9.2.2 Type II
5.9.3 LG Life Science Metabolism Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
5.9.4 Main Business/Business Overview
5.10 Metsubishi Tanabe Pharma
5.10.2 Metabolism Drugs Product Type, Application and Specification
5.10.2.1 Type I
5.10.2.2 Type II
5.10.3 Metsubishi Tanabe Pharma Metabolism Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
5.10.4 Main Business/Business Overview
6 Metabolism Drugs Manufacturing Cost Analysis
6.1 Metabolism Drugs Key Raw Materials Analysis
6.1.1 Key Raw Materials
6.1.2 Price Trend of Key Raw Materials
6.1.3 Key Suppliers of Raw Materials
6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
6.2.1 Raw Materials
6.2.2 Labor Cost
6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Metabolism Drugs
7 Industrial Chain, Sourcing Strategy and Downstream Buyers
7.1 Metabolism Drugs Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Metabolism Drugs Major Manufacturers in 2015
7.4 Downstream Buyers
8 Marketing Strategy Analysis, Distributors/Traders
8.1 Marketing Channel
8.1.1 Direct Marketing
8.1.2 Indirect Marketing
8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
8.2.1 Pricing Strategy
8.2.2 Brand Strategy
8.2.3 Target Client
8.3 Distributors/Traders List
9 Market Effect Factors Analysis
9.1 Technology Progress/Risk
9.1.1 Substitutes Threat
9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change
10 United States Metabolism Drugs Market Forecast (2016-2021)
10.1 United States Metabolism Drugs Sales, Revenue Forecast (2016-2021)
10.2 United States Metabolism Drugs Sales Forecast by Type (2016-2021)
10.3 United States Metabolism Drugs Sales Forecast by Application (2016-2021)
10.4 Metabolism Drugs Price Forecast (2016-2021)
11 Research Findings and Conclusion
12 Appendix
Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer
List of Tables and Figures
Figure Picture of Metabolism Drugs
Table Classification of Metabolism Drugs
Figure United States Sales Market Share of Metabolism Drugs by Type in 2015
Figure Glycogen Metabolism Disease Drug Picture
Figure Lipid Metabolism Disease Drug Picture
Figure Amino Acid Metabolism Drug Picture
Figure Other Picture
Table Application of Metabolism Drugs
Figure United States Sales Market Share of Metabolism Drugs by Application in 2015
Figure Hospital Examples
Figure Retail Pharmacy Examples
Figure Others Examples
Figure United States Metabolism Drugs Sales and Growth Rate (2011-2021)
Figure United States Metabolism Drugs Revenue and Growth Rate (2011-2021)
Table United States Metabolism Drugs Sales of Key Manufacturers (2015 and 2016)
Table United States Metabolism Drugs Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Metabolism Drugs Sales Share by Manufacturers
Figure 2016 Metabolism Drugs Sales Share by Manufacturers
Table United States Metabolism Drugs Revenue by Manufacturers (2015 and 2016)
Table United States Metabolism Drugs Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Metabolism Drugs Revenue Share by Manufacturers
Table 2016 United States Metabolism Drugs Revenue Share by Manufacturers
Table United States Market Metabolism Drugs Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Metabolism Drugs Average Price of Key Manufacturers in 2015
Figure Metabolism Drugs Market Share of Top 3 Manufacturers
Figure Metabolism Drugs Market Share of Top 5 Manufacturers
Table United States Metabolism Drugs Sales by Type (2011-2016)
Table United States Metabolism Drugs Sales Share by Type (2011-2016)
Figure United States Metabolism Drugs Sales Market Share by Type in 2015
Table United States Metabolism Drugs Revenue and Market Share by Type (2011-2016)
Table United States Metabolism Drugs Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Metabolism Drugs by Type (2011-2016)
Table United States Metabolism Drugs Price by Type (2011-2016)
Figure United States Metabolism Drugs Sales Growth Rate by Type (2011-2016)
Table United States Metabolism Drugs Sales by Application (2011-2016)
Table United States Metabolism Drugs Sales Market Share by Application (2011-2016)
Figure United States Metabolism Drugs Sales Market Share by Application in 2015
Table United States Metabolism Drugs Sales Growth Rate by Application (2011-2016)
Figure United States Metabolism Drugs Sales Growth Rate by Application (2011-2016)
Table Merck Basic Information List
Table Merck Metabolism Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Merck Metabolism Drugs Sales Market Share (2011-2016)
Table Novartis Basic Information List
Table Novartis Metabolism Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Novartis Metabolism Drugs Sales Market Share (2011-2016)
Table Takeda Pharmaceutical Basic Information List
Table Takeda Pharmaceutical Metabolism Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Takeda Pharmaceutical Metabolism Drugs Sales Market Share (2011-2016)
Table Astra Zeneca Basic Information List
Table Astra Zeneca Metabolism Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Astra Zeneca Metabolism Drugs Sales Market Share (2011-2016)
Table Beohrigher Ingelheim Basic Information List
Table Beohrigher Ingelheim Metabolism Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Beohrigher Ingelheim Metabolism Drugs Sales Market Share (2011-2016)
Table KOWA Basic Information List
Table KOWA Metabolism Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table KOWA Metabolism Drugs Sales Market Share (2011-2016)
Table Kythera Basic Information List
Table Kythera Metabolism Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Kythera Metabolism Drugs Sales Market Share (2011-2016)
Table Fuji yakuhin Basic Information List
Table Fuji yakuhin Metabolism Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Fuji yakuhin Metabolism Drugs Sales Market Share (2011-2016)
Table LG Life Science Basic Information List
Table LG Life Science Metabolism Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table LG Life Science Metabolism Drugs Sales Market Share (2011-2016)
Table Metsubishi Tanabe Pharma Basic Information List
Table Metsubishi Tanabe Pharma Metabolism Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Metsubishi Tanabe Pharma Metabolism Drugs Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Metabolism Drugs
Figure Manufacturing Process Analysis of Metabolism Drugs
Figure Metabolism Drugs Industrial Chain Analysis
Table Raw Materials Sources of Metabolism Drugs Major Manufacturers in 2015
Table Major Buyers of Metabolism Drugs
Table Distributors/Traders List
Figure United States Metabolism Drugs Production and Growth Rate Forecast (2016-2021)
Figure United States Metabolism Drugs Revenue and Growth Rate Forecast (2016-2021)
Table United States Metabolism Drugs Production Forecast by Type (2016-2021)
Table United States Metabolism Drugs Consumption Forecast by Application (2016-2021)
  • Renewable Energy Sources Needs To Boost Global Microgrids Market
    The global market for microgrid was worth US$13.3 billion in 2015, and is anticipated to touch an estimate of US$35.2 billion by 2020. Dealers in the market for microgrids are incessantly improving the network hosting capability for renewable energy resources to excerpt an extreme amount from it, in addition to commercialization of classically costly renewable […]
  • Manufacturing Trends In The Coming Days
    The manufacturing industry may be encountering some breezes, but it is irrefutably in the middle of a technological revival that is altering the appearance, structures, and practices of the modern factory. Notwithstanding the jeopardies and in spite of recent history industrial manufacturing enterprises cannot afford to disregard these developments. Few of the trends to look […]
  • Top 10 Emerging Technologies
    The World Economic Forum (WEF) and Scientific American lately unveiled the major technological innovation list of the top ten emerging technologies. This list emphasizes on the technological developments which have the supremacy to transform industries, protect the planet, and improve lives. It also presents an opening to discuss any societal, human, economic or environmental jeopardies […]
  • Global Biosimilars Market To Be Led By Novartis by 2020
    Biologics, which are typically inoculated or injected, are formed in living entities, making them more challenging and costly to manufacture than the usual pills contrived from chemicals. Observing that mock-ups are mostly identical to the prototypes has also modelled specific scientific and regulatory tasks. But the US FDA and European supervisors lately have acknowledged new […]
  • Global Thyroid Gland Disorder Treatment Market To Grow Steadily
    The global thyroid gland disorder treatment market was worth US$1.8 billion in 2014 and is projected to reach a market value of US$2.4 billion in 2023 intensifying at a CAGR of 3.1% from 2015 to 2023.  The thyroid gland produces thyroid hormones that control some of the most essential functions in the human body such as stimulating […]
  • Asia-Pacific Minocycline Hydrochloride Market by Manufacturers, Regions, Type and Application, Forecast to 2022
    Published: 27-Apr-2017        Price: US 4480 Onwards        Pages: 123
    Minocycline Hydrochloride, also called minocycline HCL, is a broad-spectrum tetracycline antibiotic, and has a broader spectrum than the other members of the group. It is a bacteriostatic antibiotic, classified as a long-acting type. As a result of its long half-life it generally has serum levels 2-4 times that of the simple water-soluble tetracyclines. The CAS?Number?is 13614-98-7.Scope of the Report:This report focuses on the Minocycline Hydrochloride in Asia-Pacific mar......
  • Global Neutropenia Treatment Market 2017-2021
    Published: 26-Apr-2017        Price: US 3500 Onwards        Pages: 70
    Neutropenia is an abnormal condition, characterized by critically low levels of circulating neutrophils, a type of WBC found in the blood. These cells make up for the majority of circulating lymphocytes and help defend the body against infections by bacteria, viruses, and other pathogenic organisms. Decrease in the neutrophil count in blood makes a patient susceptible to infections and may even prove fatal. Therefore, the condition requires immediate prophylaxis. The analysts forecast......
  • Global Hyoscine-N-Butyl Bromide Market by Manufacturers, Countries, Type and Application, Forecast to 2022
    Published: 26-Apr-2017        Price: US 3480 Onwards        Pages: 118
    Hyoscine-N-Butyl Bromideis obtained from a species of the plant genus Duboisia. It is mainly classified as an antispasmodic, which means that it is a drug used to suppress of muscle spasms, or involuntary contractions.Scope of the Report:This report focuses on the Hyoscine-N-Butyl Bromide in Global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and......
  • Global Medical Grade Hydrogel Market by Manufacturers, Countries, Type and Application, Forecast to 2022
    Published: 26-Apr-2017        Price: US 3480 Onwards        Pages: 117
    Hydrogel is gel-like or colloidal substances made of water and solids. Hydrogels are highly absorbent (they can contain over 90% water) natural or synthetic polymeric networks. It is widely used in medical fields, industrial fields, consumer goods etc.Scope of the Report:This report focuses on the Medical Grade Hydrogel in Global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on ......
  • North America Procalcitonin (CAS 56645-65-9) Market by Manufacturers, Countries, Type and Application, Forecast to 2022
    Published: 26-Apr-2017        Price: US 4480 Onwards        Pages: 116
    Procalcitonin (PCT) is a 116 amino acid residue protein with a molecular weight of approximately 13kDa. Procalcitonin is a peptide hormone mainly produced by the C cells of the thyroid and certain endocrine cells of the lung. Under normal expression conditions, procalcitonin is immediately cleaved into three specific fragments, an N terminal residue, calcitonin and katacalcin.Scope of the Report:This report focuses on the Procalcitonin (CAS 56645-65-9) in North America mar......
  • Global Dyslipidemia Drugs Market Professional Survey Report 2017
    Published: 26-Apr-2017        Price: US 3500 Onwards        Pages: 113
    This report studies Dyslipidemia Drugs in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering - AstraZeneca - Merck - Pfizer - Bayer - Abbott Laboratories......
  • Global Measles Vaccine Market Research Report 2017
    Published: 26-Apr-2017        Price: US 2900 Onwards        Pages: 116
    In this report, the global Measles Vaccine market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Measles Vaccine in these regions, from 2012 to 2022 (forecast), covering - North America - Europe - China - Jap......
  • Global Oral Rotavirus Vaccine Market Research Report 2017
    Published: 26-Apr-2017        Price: US 2900 Onwards        Pages: 102
    In this report, the global Oral Rotavirus Vaccine market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Oral Rotavirus Vaccine in these regions, from 2012 to 2022 (forecast), covering - North America - Europe - Chin......
  • EMEA (Europe, Middle East and Africa) Anti-Infective Drugs Market Report 2017
    Published: 26-Apr-2017        Price: US 4000 Onwards        Pages: 110
    In this report, the EMEA Anti-Infective Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K MT), revenue (Million USD), market share and growth rate of Anti-Infective Drugs for these regions, from 2012 to 2022 (forecast) - Europe: Germany, France, UK, Russia, Italy and Benelux;......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs